Background Throughout the surge of the COVID-19 pandemic high rate of chronic diseases
have been reported, including respiratory diseases and cardiovascular diseases. The …

Background COVID-19 accounts for more than half a billion deaths globally. The clinical
manifestations may vary in due course. Despite several studies aimed at determining the …

Aims The prevalence and prognostic implications of coronary artery disease (CAD) in
patients infected by the novel coronavirus 2019 (COVID-19) disease remain unclear …

Simple Summary As of October 2021, over 245 million people have been infected and
nearly 5 million have died due to COVID-19. Atherosclerosis is a lipid-driven chronic …

Coronary artery disease (CAD) is the leading cause of death worldwide. Patients with pre-
existing CAD were shown to have a more severe course of COVID-19, but this association …

Abstract Objective Since the World Health Organization (WHO) announced coronavirus
disease 2019 (COVID-19) had become a global pandemic on March 11, 2020, the number …

Objective Among patients with Coronavirus disease 2019 (COVID-19), coronary artery
disease (CAD) has been identified as a high-risk condition. We aimed to assess the clinical …

Background and aim Patients with underlying cardiovascular disorders such as coronary
artery disease (CAD) are more prone to severe forms and multiple complications of COVID …

Aims To assess demographic characteristics and investigate the correlation between
cardiovascular diseases and long COVID-19 patients. Methods and Results Comprehensive …

Methods This is a retrospective study of patients who tested COVID-19 positive via reverse
transcriptase-PCR (RT-PCR) assay. We compared the characteristics and outcomes of …